机构

• 合肥物质科学研究院 [3]

采集方式

• OAI收割 [3]

_filter

_filter

_filter

筛选

浏览/检索结果: 共3条，第1-3条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Pyrotinib plus capecitabine for patients with HER2-positive metastatic breast cancer and brain metastases (PERMEATE trial): overall survival results from a multicenter, single-arm, two-cohort, phase 2 trial 期刊论文  OAI收割 ECLINICALMEDICINE, 2024, 卷号: 76 作者:  Yan, Min;  Ouyang, Quchang;  Sun, Tao;  Niu, Limin;  Yang, Jin   |  收藏  |  浏览/下载：15/0  |  提交时间：2024/11/20 Pyrotinib  Human epidermal growth factor receptor 2  Breast cancer  Brain metastases  Overall survival   A prospective, open-label, multicenter phase IV clinical trial on the safety and efficacy of lobaplatin-based chemotherapy in advanced breast cancer 期刊论文  OAI收割 THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 卷号: 14 作者:  Yan, Min;  Yuan, Peng;  Ouyang, Quchang;  Cheng, Ying;  Han, Guohui   |  收藏  |  浏览/下载：67/0  |  提交时间：2022/12/23 breast cancer  chemotherapy  efficacy  lobaplatin  neoplasm metastasis  safety   Pyrotinib plus capecitabine for HER2-positive metastatic breast cancer patients with brain metastases (PERMEATE): A multicenter, single-arm phase II study. 期刊论文  OAI收割 JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39 作者:  Yan, Min;  Ouyang, Quchang;  Sun, Tao;  Niu, Limin;  Yang, Jin   |  收藏  |  浏览/下载：22/0  |  提交时间：2022/01/10